Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastric, Gastroesophageal Junction (GEJ), or Esophageal Cancer - Final Report
Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.